nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—SIGMAR1—Donepezil—Alzheimer's disease	0.205	0.466	CbGbCtD
Fluvoxamine—SLC6A4—Alzheimer's disease	0.178	0.587	CbGaD
Fluvoxamine—CYP2D6—Alzheimer's disease	0.125	0.413	CbGaD
Fluvoxamine—CYP2B6—Memantine—Alzheimer's disease	0.0481	0.109	CbGbCtD
Fluvoxamine—CYP2D6—Rivastigmine—Alzheimer's disease	0.0335	0.0762	CbGbCtD
Fluvoxamine—CYP2C19—Memantine—Alzheimer's disease	0.0306	0.0695	CbGbCtD
Fluvoxamine—CYP2C9—Donepezil—Alzheimer's disease	0.0293	0.0666	CbGbCtD
Fluvoxamine—CYP2D6—Donepezil—Alzheimer's disease	0.0268	0.0609	CbGbCtD
Fluvoxamine—CYP3A4—Rivastigmine—Alzheimer's disease	0.0213	0.0484	CbGbCtD
Fluvoxamine—CYP2D6—Galantamine—Alzheimer's disease	0.0173	0.0392	CbGbCtD
Fluvoxamine—CYP3A4—Donepezil—Alzheimer's disease	0.017	0.0387	CbGbCtD
Fluvoxamine—CYP3A4—Galantamine—Alzheimer's disease	0.011	0.025	CbGbCtD
Fluvoxamine—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00129	0.188	CbGeAlD
Fluvoxamine—SLC6A3—forebrain—Alzheimer's disease	0.000338	0.0491	CbGeAlD
Fluvoxamine—SLC6A3—telencephalon—Alzheimer's disease	0.000311	0.0452	CbGeAlD
Fluvoxamine—SLC6A4—forebrain—Alzheimer's disease	0.00031	0.045	CbGeAlD
Fluvoxamine—SLC6A4—telencephalon—Alzheimer's disease	0.000285	0.0414	CbGeAlD
Fluvoxamine—SIGMAR1—telencephalon—Alzheimer's disease	0.000283	0.0411	CbGeAlD
Fluvoxamine—ABCB1—blood vessel—Alzheimer's disease	0.000204	0.0296	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—Alzheimer's disease	0.000183	0.0267	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—Alzheimer's disease	0.000177	0.0257	CbGeAlD
Fluvoxamine—CYP2E1—telencephalon—Alzheimer's disease	0.000173	0.0252	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—Alzheimer's disease	0.000173	0.0251	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—Alzheimer's disease	0.000168	0.0244	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—Alzheimer's disease	0.000162	0.0235	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—Alzheimer's disease	0.000157	0.0228	CbGeAlD
Fluvoxamine—CYP2D6—forebrain—Alzheimer's disease	0.000149	0.0217	CbGeAlD
Fluvoxamine—SLC6A3—brain—Alzheimer's disease	0.00014	0.0204	CbGeAlD
Fluvoxamine—CYP2D6—telencephalon—Alzheimer's disease	0.000137	0.02	CbGeAlD
Fluvoxamine—SLC6A4—brain—Alzheimer's disease	0.000128	0.0187	CbGeAlD
Fluvoxamine—SIGMAR1—brain—Alzheimer's disease	0.000128	0.0186	CbGeAlD
Fluvoxamine—Pharyngitis—Memantine—Alzheimer's disease	0.000126	0.000624	CcSEcCtD
Fluvoxamine—Nervous system disorder—Galantamine—Alzheimer's disease	0.000125	0.000623	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000125	0.000622	CcSEcCtD
Fluvoxamine—Chills—Donepezil—Alzheimer's disease	0.000125	0.000621	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Memantine—Alzheimer's disease	0.000125	0.000621	CcSEcCtD
Fluvoxamine—Tachycardia—Galantamine—Alzheimer's disease	0.000125	0.00062	CcSEcCtD
Fluvoxamine—Oedema peripheral—Memantine—Alzheimer's disease	0.000125	0.000619	CcSEcCtD
Fluvoxamine—Arrhythmia—Donepezil—Alzheimer's disease	0.000125	0.000619	CcSEcCtD
Fluvoxamine—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000125	0.000618	CcSEcCtD
Fluvoxamine—Rhinitis—Rivastigmine—Alzheimer's disease	0.000124	0.000617	CcSEcCtD
Fluvoxamine—Urethral disorder—Memantine—Alzheimer's disease	0.000124	0.000616	CcSEcCtD
Fluvoxamine—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000124	0.000615	CcSEcCtD
Fluvoxamine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000124	0.000615	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000124	0.000614	CcSEcCtD
Fluvoxamine—Hallucination—Rivastigmine—Alzheimer's disease	0.000123	0.000612	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000123	0.000612	CcSEcCtD
Fluvoxamine—Alopecia—Donepezil—Alzheimer's disease	0.000123	0.000612	CcSEcCtD
Fluvoxamine—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000123	0.00061	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000122	0.000607	CcSEcCtD
Fluvoxamine—Mental disorder—Donepezil—Alzheimer's disease	0.000122	0.000607	CcSEcCtD
Fluvoxamine—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000122	0.000606	CcSEcCtD
Fluvoxamine—Visual impairment—Memantine—Alzheimer's disease	0.000122	0.000606	CcSEcCtD
Fluvoxamine—Anorexia—Galantamine—Alzheimer's disease	0.000122	0.000605	CcSEcCtD
Fluvoxamine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000122	0.000603	CcSEcCtD
Fluvoxamine—Malnutrition—Donepezil—Alzheimer's disease	0.000121	0.000603	CcSEcCtD
Fluvoxamine—ABCB1—embryo—Alzheimer's disease	0.000121	0.0177	CbGeAlD
Fluvoxamine—Erythema multiforme—Memantine—Alzheimer's disease	0.00012	0.000594	CcSEcCtD
Fluvoxamine—Flatulence—Donepezil—Alzheimer's disease	0.00012	0.000594	CcSEcCtD
Fluvoxamine—Hypotension—Galantamine—Alzheimer's disease	0.00012	0.000593	CcSEcCtD
Fluvoxamine—Visual impairment—Rivastigmine—Alzheimer's disease	0.000119	0.000593	CcSEcCtD
Fluvoxamine—Tension—Donepezil—Alzheimer's disease	0.000119	0.000592	CcSEcCtD
Fluvoxamine—Dysgeusia—Donepezil—Alzheimer's disease	0.000119	0.00059	CcSEcCtD
Fluvoxamine—Eye disorder—Memantine—Alzheimer's disease	0.000118	0.000588	CcSEcCtD
Fluvoxamine—Tinnitus—Memantine—Alzheimer's disease	0.000118	0.000586	CcSEcCtD
Fluvoxamine—Nervousness—Donepezil—Alzheimer's disease	0.000118	0.000585	CcSEcCtD
Fluvoxamine—Cardiac disorder—Memantine—Alzheimer's disease	0.000118	0.000584	CcSEcCtD
Fluvoxamine—Back pain—Donepezil—Alzheimer's disease	0.000118	0.000583	CcSEcCtD
Fluvoxamine—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000117	0.000582	CcSEcCtD
Fluvoxamine—Muscle spasms—Donepezil—Alzheimer's disease	0.000117	0.00058	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000117	0.000578	CcSEcCtD
Fluvoxamine—Eye disorder—Rivastigmine—Alzheimer's disease	0.000116	0.000575	CcSEcCtD
Fluvoxamine—Insomnia—Galantamine—Alzheimer's disease	0.000116	0.000574	CcSEcCtD
Fluvoxamine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000116	0.000573	CcSEcCtD
Fluvoxamine—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000115	0.000571	CcSEcCtD
Fluvoxamine—Angiopathy—Memantine—Alzheimer's disease	0.000115	0.00057	CcSEcCtD
Fluvoxamine—Paraesthesia—Galantamine—Alzheimer's disease	0.000115	0.00057	CcSEcCtD
Fluvoxamine—Vision blurred—Donepezil—Alzheimer's disease	0.000114	0.000568	CcSEcCtD
Fluvoxamine—Tremor—Donepezil—Alzheimer's disease	0.000114	0.000565	CcSEcCtD
Fluvoxamine—Somnolence—Galantamine—Alzheimer's disease	0.000114	0.000564	CcSEcCtD
Fluvoxamine—Chills—Memantine—Alzheimer's disease	0.000114	0.000564	CcSEcCtD
Fluvoxamine—Arrhythmia—Memantine—Alzheimer's disease	0.000113	0.000562	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000113	0.000559	CcSEcCtD
Fluvoxamine—Dyspepsia—Galantamine—Alzheimer's disease	0.000113	0.000559	CcSEcCtD
Fluvoxamine—Angiopathy—Rivastigmine—Alzheimer's disease	0.000112	0.000558	CcSEcCtD
Fluvoxamine—Anaemia—Donepezil—Alzheimer's disease	0.000112	0.000557	CcSEcCtD
Fluvoxamine—CYP1A1—nervous system—Alzheimer's disease	0.000112	0.0163	CbGeAlD
Fluvoxamine—Alopecia—Memantine—Alzheimer's disease	0.000112	0.000556	CcSEcCtD
Fluvoxamine—Agitation—Donepezil—Alzheimer's disease	0.000112	0.000554	CcSEcCtD
Fluvoxamine—Chills—Rivastigmine—Alzheimer's disease	0.000111	0.000552	CcSEcCtD
Fluvoxamine—Decreased appetite—Galantamine—Alzheimer's disease	0.000111	0.000552	CcSEcCtD
Fluvoxamine—Mental disorder—Memantine—Alzheimer's disease	0.000111	0.000551	CcSEcCtD
Fluvoxamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000111	0.000549	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00011	0.000548	CcSEcCtD
Fluvoxamine—Malnutrition—Memantine—Alzheimer's disease	0.00011	0.000547	CcSEcCtD
Fluvoxamine—Fatigue—Galantamine—Alzheimer's disease	0.00011	0.000547	CcSEcCtD
Fluvoxamine—Malaise—Donepezil—Alzheimer's disease	0.00011	0.000544	CcSEcCtD
Fluvoxamine—Alopecia—Rivastigmine—Alzheimer's disease	0.00011	0.000544	CcSEcCtD
Fluvoxamine—Constipation—Galantamine—Alzheimer's disease	0.000109	0.000543	CcSEcCtD
Fluvoxamine—Vertigo—Donepezil—Alzheimer's disease	0.000109	0.000542	CcSEcCtD
Fluvoxamine—CYP2B6—nervous system—Alzheimer's disease	0.000109	0.0159	CbGeAlD
Fluvoxamine—Syncope—Donepezil—Alzheimer's disease	0.000109	0.000541	CcSEcCtD
Fluvoxamine—Flatulence—Memantine—Alzheimer's disease	0.000109	0.000539	CcSEcCtD
Fluvoxamine—Mental disorder—Rivastigmine—Alzheimer's disease	0.000109	0.000539	CcSEcCtD
Fluvoxamine—Tension—Memantine—Alzheimer's disease	0.000108	0.000537	CcSEcCtD
Fluvoxamine—CYP1A1—central nervous system—Alzheimer's disease	0.000108	0.0157	CbGeAlD
Fluvoxamine—Dysgeusia—Memantine—Alzheimer's disease	0.000108	0.000536	CcSEcCtD
Fluvoxamine—Malnutrition—Rivastigmine—Alzheimer's disease	0.000108	0.000535	CcSEcCtD
Fluvoxamine—ABCB1—forebrain—Alzheimer's disease	0.000107	0.0156	CbGeAlD
Fluvoxamine—Nervousness—Memantine—Alzheimer's disease	0.000107	0.000532	CcSEcCtD
Fluvoxamine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000107	0.00053	CcSEcCtD
Fluvoxamine—Back pain—Memantine—Alzheimer's disease	0.000107	0.000529	CcSEcCtD
Fluvoxamine—Flatulence—Rivastigmine—Alzheimer's disease	0.000106	0.000528	CcSEcCtD
Fluvoxamine—Cough—Donepezil—Alzheimer's disease	0.000106	0.000526	CcSEcCtD
Fluvoxamine—Tension—Rivastigmine—Alzheimer's disease	0.000106	0.000525	CcSEcCtD
Fluvoxamine—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000106	0.000524	CcSEcCtD
Fluvoxamine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000105	0.000523	CcSEcCtD
Fluvoxamine—Convulsion—Donepezil—Alzheimer's disease	0.000105	0.000522	CcSEcCtD
Fluvoxamine—CYP2B6—central nervous system—Alzheimer's disease	0.000105	0.0153	CbGeAlD
Fluvoxamine—Hypertension—Donepezil—Alzheimer's disease	0.000105	0.00052	CcSEcCtD
Fluvoxamine—Nervousness—Rivastigmine—Alzheimer's disease	0.000105	0.00052	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000105	0.000519	CcSEcCtD
Fluvoxamine—Back pain—Rivastigmine—Alzheimer's disease	0.000104	0.000518	CcSEcCtD
Fluvoxamine—Vision blurred—Memantine—Alzheimer's disease	0.000104	0.000516	CcSEcCtD
Fluvoxamine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000104	0.000515	CcSEcCtD
Fluvoxamine—Chest pain—Donepezil—Alzheimer's disease	0.000103	0.000513	CcSEcCtD
Fluvoxamine—Arthralgia—Donepezil—Alzheimer's disease	0.000103	0.000513	CcSEcCtD
Fluvoxamine—Myalgia—Donepezil—Alzheimer's disease	0.000103	0.000513	CcSEcCtD
Fluvoxamine—Tremor—Memantine—Alzheimer's disease	0.000103	0.000513	CcSEcCtD
Fluvoxamine—Anxiety—Donepezil—Alzheimer's disease	0.000103	0.000511	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Memantine—Alzheimer's disease	0.000102	0.000508	CcSEcCtD
Fluvoxamine—CYP2E1—nervous system—Alzheimer's disease	0.000102	0.0149	CbGeAlD
Fluvoxamine—Discomfort—Donepezil—Alzheimer's disease	0.000102	0.000507	CcSEcCtD
Fluvoxamine—Anaemia—Memantine—Alzheimer's disease	0.000102	0.000506	CcSEcCtD
Fluvoxamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.000102	0.000505	CcSEcCtD
Fluvoxamine—Agitation—Memantine—Alzheimer's disease	0.000101	0.000503	CcSEcCtD
Fluvoxamine—Dry mouth—Donepezil—Alzheimer's disease	0.000101	0.000502	CcSEcCtD
Fluvoxamine—Body temperature increased—Galantamine—Alzheimer's disease	0.000101	0.000502	CcSEcCtD
Fluvoxamine—Abdominal pain—Galantamine—Alzheimer's disease	0.000101	0.000502	CcSEcCtD
Fluvoxamine—Tremor—Rivastigmine—Alzheimer's disease	0.000101	0.000502	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.0001	0.000497	CcSEcCtD
Fluvoxamine—Confusional state—Donepezil—Alzheimer's disease	0.0001	0.000496	CcSEcCtD
Fluvoxamine—Anaemia—Rivastigmine—Alzheimer's disease	9.97e-05	0.000495	CcSEcCtD
Fluvoxamine—Malaise—Memantine—Alzheimer's disease	9.95e-05	0.000494	CcSEcCtD
Fluvoxamine—Agitation—Rivastigmine—Alzheimer's disease	9.92e-05	0.000492	CcSEcCtD
Fluvoxamine—Oedema—Donepezil—Alzheimer's disease	9.92e-05	0.000492	CcSEcCtD
Fluvoxamine—Vertigo—Memantine—Alzheimer's disease	9.91e-05	0.000492	CcSEcCtD
Fluvoxamine—Syncope—Memantine—Alzheimer's disease	9.89e-05	0.000491	CcSEcCtD
Fluvoxamine—Leukopenia—Memantine—Alzheimer's disease	9.87e-05	0.00049	CcSEcCtD
Fluvoxamine—ABCB1—telencephalon—Alzheimer's disease	9.87e-05	0.0144	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—Alzheimer's disease	9.85e-05	0.0143	CbGeAlD
Fluvoxamine—Infection—Donepezil—Alzheimer's disease	9.85e-05	0.000489	CcSEcCtD
Fluvoxamine—Shock—Donepezil—Alzheimer's disease	9.75e-05	0.000484	CcSEcCtD
Fluvoxamine—Palpitations—Memantine—Alzheimer's disease	9.75e-05	0.000484	CcSEcCtD
Fluvoxamine—Malaise—Rivastigmine—Alzheimer's disease	9.73e-05	0.000483	CcSEcCtD
Fluvoxamine—Nervous system disorder—Donepezil—Alzheimer's disease	9.72e-05	0.000482	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Donepezil—Alzheimer's disease	9.71e-05	0.000482	CcSEcCtD
Fluvoxamine—Vertigo—Rivastigmine—Alzheimer's disease	9.7e-05	0.000481	CcSEcCtD
Fluvoxamine—Loss of consciousness—Memantine—Alzheimer's disease	9.7e-05	0.000481	CcSEcCtD
Fluvoxamine—Syncope—Rivastigmine—Alzheimer's disease	9.68e-05	0.00048	CcSEcCtD
Fluvoxamine—CYP2E1—cerebellum—Alzheimer's disease	9.63e-05	0.014	CbGeAlD
Fluvoxamine—Cough—Memantine—Alzheimer's disease	9.63e-05	0.000478	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Donepezil—Alzheimer's disease	9.59e-05	0.000476	CcSEcCtD
Fluvoxamine—Convulsion—Memantine—Alzheimer's disease	9.56e-05	0.000474	CcSEcCtD
Fluvoxamine—Palpitations—Rivastigmine—Alzheimer's disease	9.54e-05	0.000473	CcSEcCtD
Fluvoxamine—Hypertension—Memantine—Alzheimer's disease	9.52e-05	0.000473	CcSEcCtD
Fluvoxamine—Loss of consciousness—Rivastigmine—Alzheimer's disease	9.48e-05	0.000471	CcSEcCtD
Fluvoxamine—Anorexia—Donepezil—Alzheimer's disease	9.45e-05	0.000469	CcSEcCtD
Fluvoxamine—Hypersensitivity—Galantamine—Alzheimer's disease	9.43e-05	0.000468	CcSEcCtD
Fluvoxamine—Cough—Rivastigmine—Alzheimer's disease	9.42e-05	0.000467	CcSEcCtD
Fluvoxamine—Myalgia—Memantine—Alzheimer's disease	9.39e-05	0.000466	CcSEcCtD
Fluvoxamine—Chest pain—Memantine—Alzheimer's disease	9.39e-05	0.000466	CcSEcCtD
Fluvoxamine—Arthralgia—Memantine—Alzheimer's disease	9.39e-05	0.000466	CcSEcCtD
Fluvoxamine—Anxiety—Memantine—Alzheimer's disease	9.36e-05	0.000464	CcSEcCtD
Fluvoxamine—Convulsion—Rivastigmine—Alzheimer's disease	9.35e-05	0.000464	CcSEcCtD
Fluvoxamine—Hypertension—Rivastigmine—Alzheimer's disease	9.32e-05	0.000462	CcSEcCtD
Fluvoxamine—Discomfort—Memantine—Alzheimer's disease	9.28e-05	0.00046	CcSEcCtD
Fluvoxamine—Hypotension—Donepezil—Alzheimer's disease	9.26e-05	0.00046	CcSEcCtD
Fluvoxamine—Myalgia—Rivastigmine—Alzheimer's disease	9.19e-05	0.000456	CcSEcCtD
Fluvoxamine—Arthralgia—Rivastigmine—Alzheimer's disease	9.19e-05	0.000456	CcSEcCtD
Fluvoxamine—Chest pain—Rivastigmine—Alzheimer's disease	9.19e-05	0.000456	CcSEcCtD
Fluvoxamine—Dry mouth—Memantine—Alzheimer's disease	9.18e-05	0.000456	CcSEcCtD
Fluvoxamine—Asthenia—Galantamine—Alzheimer's disease	9.18e-05	0.000455	CcSEcCtD
Fluvoxamine—Anxiety—Rivastigmine—Alzheimer's disease	9.16e-05	0.000454	CcSEcCtD
Fluvoxamine—Confusional state—Memantine—Alzheimer's disease	9.08e-05	0.00045	CcSEcCtD
Fluvoxamine—Discomfort—Rivastigmine—Alzheimer's disease	9.08e-05	0.00045	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	9.03e-05	0.000448	CcSEcCtD
Fluvoxamine—Oedema—Memantine—Alzheimer's disease	9e-05	0.000447	CcSEcCtD
Fluvoxamine—Dry mouth—Rivastigmine—Alzheimer's disease	8.99e-05	0.000446	CcSEcCtD
Fluvoxamine—Insomnia—Donepezil—Alzheimer's disease	8.97e-05	0.000445	CcSEcCtD
Fluvoxamine—Infection—Memantine—Alzheimer's disease	8.94e-05	0.000444	CcSEcCtD
Fluvoxamine—Paraesthesia—Donepezil—Alzheimer's disease	8.9e-05	0.000442	CcSEcCtD
Fluvoxamine—Confusional state—Rivastigmine—Alzheimer's disease	8.88e-05	0.000441	CcSEcCtD
Fluvoxamine—Shock—Memantine—Alzheimer's disease	8.86e-05	0.000439	CcSEcCtD
Fluvoxamine—Dyspnoea—Donepezil—Alzheimer's disease	8.84e-05	0.000439	CcSEcCtD
Fluvoxamine—Nervous system disorder—Memantine—Alzheimer's disease	8.83e-05	0.000438	CcSEcCtD
Fluvoxamine—Somnolence—Donepezil—Alzheimer's disease	8.81e-05	0.000437	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Memantine—Alzheimer's disease	8.81e-05	0.000437	CcSEcCtD
Fluvoxamine—Oedema—Rivastigmine—Alzheimer's disease	8.81e-05	0.000437	CcSEcCtD
Fluvoxamine—Tachycardia—Memantine—Alzheimer's disease	8.79e-05	0.000436	CcSEcCtD
Fluvoxamine—Diarrhoea—Galantamine—Alzheimer's disease	8.75e-05	0.000434	CcSEcCtD
Fluvoxamine—Infection—Rivastigmine—Alzheimer's disease	8.75e-05	0.000434	CcSEcCtD
Fluvoxamine—Dyspepsia—Donepezil—Alzheimer's disease	8.73e-05	0.000433	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Memantine—Alzheimer's disease	8.7e-05	0.000432	CcSEcCtD
Fluvoxamine—Shock—Rivastigmine—Alzheimer's disease	8.66e-05	0.00043	CcSEcCtD
Fluvoxamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	8.64e-05	0.000429	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	8.62e-05	0.000428	CcSEcCtD
Fluvoxamine—Decreased appetite—Donepezil—Alzheimer's disease	8.62e-05	0.000428	CcSEcCtD
Fluvoxamine—Tachycardia—Rivastigmine—Alzheimer's disease	8.6e-05	0.000426	CcSEcCtD
Fluvoxamine—Anorexia—Memantine—Alzheimer's disease	8.58e-05	0.000426	CcSEcCtD
Fluvoxamine—CYP1A1—brain—Alzheimer's disease	8.58e-05	0.0125	CbGeAlD
Fluvoxamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	8.56e-05	0.000425	CcSEcCtD
Fluvoxamine—Fatigue—Donepezil—Alzheimer's disease	8.55e-05	0.000424	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	8.51e-05	0.000422	CcSEcCtD
Fluvoxamine—Pain—Donepezil—Alzheimer's disease	8.48e-05	0.000421	CcSEcCtD
Fluvoxamine—Constipation—Donepezil—Alzheimer's disease	8.48e-05	0.000421	CcSEcCtD
Fluvoxamine—Dizziness—Galantamine—Alzheimer's disease	8.46e-05	0.00042	CcSEcCtD
Fluvoxamine—Hypotension—Memantine—Alzheimer's disease	8.41e-05	0.000417	CcSEcCtD
Fluvoxamine—Anorexia—Rivastigmine—Alzheimer's disease	8.4e-05	0.000417	CcSEcCtD
Fluvoxamine—CYP2B6—brain—Alzheimer's disease	8.34e-05	0.0121	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—Alzheimer's disease	8.23e-05	0.012	CbGeAlD
Fluvoxamine—Hypotension—Rivastigmine—Alzheimer's disease	8.23e-05	0.000408	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	8.2e-05	0.000407	CcSEcCtD
Fluvoxamine—Feeling abnormal—Donepezil—Alzheimer's disease	8.17e-05	0.000405	CcSEcCtD
Fluvoxamine—Insomnia—Memantine—Alzheimer's disease	8.14e-05	0.000404	CcSEcCtD
Fluvoxamine—Vomiting—Galantamine—Alzheimer's disease	8.13e-05	0.000404	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	8.11e-05	0.000402	CcSEcCtD
Fluvoxamine—CYP2D6—nervous system—Alzheimer's disease	8.1e-05	0.0118	CbGeAlD
Fluvoxamine—Paraesthesia—Memantine—Alzheimer's disease	8.08e-05	0.000401	CcSEcCtD
Fluvoxamine—Rash—Galantamine—Alzheimer's disease	8.07e-05	0.0004	CcSEcCtD
Fluvoxamine—Dermatitis—Galantamine—Alzheimer's disease	8.06e-05	0.0004	CcSEcCtD
Fluvoxamine—Dyspnoea—Memantine—Alzheimer's disease	8.03e-05	0.000398	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	8.02e-05	0.000398	CcSEcCtD
Fluvoxamine—Headache—Galantamine—Alzheimer's disease	8.01e-05	0.000398	CcSEcCtD
Fluvoxamine—Somnolence—Memantine—Alzheimer's disease	8e-05	0.000397	CcSEcCtD
Fluvoxamine—Insomnia—Rivastigmine—Alzheimer's disease	7.97e-05	0.000395	CcSEcCtD
Fluvoxamine—CYP3A4—central nervous system—Alzheimer's disease	7.93e-05	0.0115	CbGeAlD
Fluvoxamine—Dyspepsia—Memantine—Alzheimer's disease	7.92e-05	0.000393	CcSEcCtD
Fluvoxamine—Paraesthesia—Rivastigmine—Alzheimer's disease	7.91e-05	0.000392	CcSEcCtD
Fluvoxamine—Urticaria—Donepezil—Alzheimer's disease	7.88e-05	0.000391	CcSEcCtD
Fluvoxamine—Dyspnoea—Rivastigmine—Alzheimer's disease	7.85e-05	0.00039	CcSEcCtD
Fluvoxamine—Abdominal pain—Donepezil—Alzheimer's disease	7.84e-05	0.000389	CcSEcCtD
Fluvoxamine—Body temperature increased—Donepezil—Alzheimer's disease	7.84e-05	0.000389	CcSEcCtD
Fluvoxamine—Somnolence—Rivastigmine—Alzheimer's disease	7.83e-05	0.000388	CcSEcCtD
Fluvoxamine—Decreased appetite—Memantine—Alzheimer's disease	7.83e-05	0.000388	CcSEcCtD
Fluvoxamine—CYP2E1—brain—Alzheimer's disease	7.82e-05	0.0114	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—Alzheimer's disease	7.8e-05	0.0113	CbGeAlD
Fluvoxamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	7.77e-05	0.000386	CcSEcCtD
Fluvoxamine—Fatigue—Memantine—Alzheimer's disease	7.76e-05	0.000385	CcSEcCtD
Fluvoxamine—Dyspepsia—Rivastigmine—Alzheimer's disease	7.75e-05	0.000385	CcSEcCtD
Fluvoxamine—Pain—Memantine—Alzheimer's disease	7.7e-05	0.000382	CcSEcCtD
Fluvoxamine—Constipation—Memantine—Alzheimer's disease	7.7e-05	0.000382	CcSEcCtD
Fluvoxamine—Decreased appetite—Rivastigmine—Alzheimer's disease	7.66e-05	0.00038	CcSEcCtD
Fluvoxamine—CYP2D6—cerebellum—Alzheimer's disease	7.63e-05	0.0111	CbGeAlD
Fluvoxamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	7.6e-05	0.000377	CcSEcCtD
Fluvoxamine—Nausea—Galantamine—Alzheimer's disease	7.6e-05	0.000377	CcSEcCtD
Fluvoxamine—Fatigue—Rivastigmine—Alzheimer's disease	7.59e-05	0.000377	CcSEcCtD
Fluvoxamine—Pain—Rivastigmine—Alzheimer's disease	7.53e-05	0.000374	CcSEcCtD
Fluvoxamine—Constipation—Rivastigmine—Alzheimer's disease	7.53e-05	0.000374	CcSEcCtD
Fluvoxamine—Feeling abnormal—Memantine—Alzheimer's disease	7.42e-05	0.000368	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Memantine—Alzheimer's disease	7.36e-05	0.000365	CcSEcCtD
Fluvoxamine—Hypersensitivity—Donepezil—Alzheimer's disease	7.31e-05	0.000362	CcSEcCtD
Fluvoxamine—Feeling abnormal—Rivastigmine—Alzheimer's disease	7.26e-05	0.00036	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	7.2e-05	0.000357	CcSEcCtD
Fluvoxamine—Urticaria—Memantine—Alzheimer's disease	7.15e-05	0.000355	CcSEcCtD
Fluvoxamine—Abdominal pain—Memantine—Alzheimer's disease	7.12e-05	0.000353	CcSEcCtD
Fluvoxamine—Body temperature increased—Memantine—Alzheimer's disease	7.12e-05	0.000353	CcSEcCtD
Fluvoxamine—Asthenia—Donepezil—Alzheimer's disease	7.11e-05	0.000353	CcSEcCtD
Fluvoxamine—Pruritus—Donepezil—Alzheimer's disease	7.01e-05	0.000348	CcSEcCtD
Fluvoxamine—Urticaria—Rivastigmine—Alzheimer's disease	7e-05	0.000347	CcSEcCtD
Fluvoxamine—Abdominal pain—Rivastigmine—Alzheimer's disease	6.96e-05	0.000345	CcSEcCtD
Fluvoxamine—Body temperature increased—Rivastigmine—Alzheimer's disease	6.96e-05	0.000345	CcSEcCtD
Fluvoxamine—Diarrhoea—Donepezil—Alzheimer's disease	6.78e-05	0.000337	CcSEcCtD
Fluvoxamine—Hypersensitivity—Memantine—Alzheimer's disease	6.63e-05	0.000329	CcSEcCtD
Fluvoxamine—Dizziness—Donepezil—Alzheimer's disease	6.56e-05	0.000325	CcSEcCtD
Fluvoxamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	6.49e-05	0.000322	CcSEcCtD
Fluvoxamine—Asthenia—Memantine—Alzheimer's disease	6.46e-05	0.00032	CcSEcCtD
Fluvoxamine—Pruritus—Memantine—Alzheimer's disease	6.37e-05	0.000316	CcSEcCtD
Fluvoxamine—Asthenia—Rivastigmine—Alzheimer's disease	6.32e-05	0.000314	CcSEcCtD
Fluvoxamine—Vomiting—Donepezil—Alzheimer's disease	6.3e-05	0.000313	CcSEcCtD
Fluvoxamine—Rash—Donepezil—Alzheimer's disease	6.25e-05	0.00031	CcSEcCtD
Fluvoxamine—Dermatitis—Donepezil—Alzheimer's disease	6.25e-05	0.00031	CcSEcCtD
Fluvoxamine—Pruritus—Rivastigmine—Alzheimer's disease	6.23e-05	0.000309	CcSEcCtD
Fluvoxamine—Headache—Donepezil—Alzheimer's disease	6.21e-05	0.000308	CcSEcCtD
Fluvoxamine—CYP2D6—brain—Alzheimer's disease	6.19e-05	0.00901	CbGeAlD
Fluvoxamine—Diarrhoea—Memantine—Alzheimer's disease	6.16e-05	0.000306	CcSEcCtD
Fluvoxamine—Diarrhoea—Rivastigmine—Alzheimer's disease	6.03e-05	0.000299	CcSEcCtD
Fluvoxamine—Dizziness—Memantine—Alzheimer's disease	5.95e-05	0.000295	CcSEcCtD
Fluvoxamine—Nausea—Donepezil—Alzheimer's disease	5.89e-05	0.000292	CcSEcCtD
Fluvoxamine—ABCB1—nervous system—Alzheimer's disease	5.83e-05	0.00848	CbGeAlD
Fluvoxamine—Dizziness—Rivastigmine—Alzheimer's disease	5.82e-05	0.000289	CcSEcCtD
Fluvoxamine—Vomiting—Memantine—Alzheimer's disease	5.72e-05	0.000284	CcSEcCtD
Fluvoxamine—Rash—Memantine—Alzheimer's disease	5.68e-05	0.000282	CcSEcCtD
Fluvoxamine—Dermatitis—Memantine—Alzheimer's disease	5.67e-05	0.000281	CcSEcCtD
Fluvoxamine—Headache—Memantine—Alzheimer's disease	5.64e-05	0.00028	CcSEcCtD
Fluvoxamine—ABCB1—central nervous system—Alzheimer's disease	5.61e-05	0.00816	CbGeAlD
Fluvoxamine—Vomiting—Rivastigmine—Alzheimer's disease	5.6e-05	0.000278	CcSEcCtD
Fluvoxamine—Rash—Rivastigmine—Alzheimer's disease	5.55e-05	0.000276	CcSEcCtD
Fluvoxamine—Dermatitis—Rivastigmine—Alzheimer's disease	5.55e-05	0.000275	CcSEcCtD
Fluvoxamine—Headache—Rivastigmine—Alzheimer's disease	5.52e-05	0.000274	CcSEcCtD
Fluvoxamine—ABCB1—cerebellum—Alzheimer's disease	5.48e-05	0.00798	CbGeAlD
Fluvoxamine—Nausea—Memantine—Alzheimer's disease	5.35e-05	0.000265	CcSEcCtD
Fluvoxamine—Nausea—Rivastigmine—Alzheimer's disease	5.23e-05	0.00026	CcSEcCtD
Fluvoxamine—ABCB1—brain—Alzheimer's disease	4.46e-05	0.00648	CbGeAlD
Fluvoxamine—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	7.27e-06	0.000151	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ENO1—Alzheimer's disease	7.23e-06	0.00015	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS1—Alzheimer's disease	7.23e-06	0.00015	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOB—Alzheimer's disease	7.21e-06	0.00015	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARGC1A—Alzheimer's disease	7.17e-06	0.000149	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—HMOX1—Alzheimer's disease	7.13e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ACHE—Alzheimer's disease	7.13e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2D6—Alzheimer's disease	7.09e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ENO1—Alzheimer's disease	7.08e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS1—Alzheimer's disease	7.08e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ENO1—Alzheimer's disease	7.07e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS1—Alzheimer's disease	7.07e-06	0.000147	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INPP5D—Alzheimer's disease	7.04e-06	0.000146	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOB—Alzheimer's disease	7.04e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ND1—Alzheimer's disease	7.02e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	7.01e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP2D6—Alzheimer's disease	6.95e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	6.94e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2D6—Alzheimer's disease	6.93e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CHAT—Alzheimer's disease	6.92e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TPI1—Alzheimer's disease	6.92e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.86e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CHAT—Alzheimer's disease	6.86e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TPI1—Alzheimer's disease	6.86e-06	0.000143	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.8e-06	0.000141	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GAPDH—Alzheimer's disease	6.77e-06	0.000141	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—BCHE—Alzheimer's disease	6.72e-06	0.00014	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—A2M—Alzheimer's disease	6.7e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS1—Alzheimer's disease	6.68e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ENO1—Alzheimer's disease	6.68e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOB—Alzheimer's disease	6.63e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—BCHE—Alzheimer's disease	6.58e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOB—Alzheimer's disease	6.57e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—BCHE—Alzheimer's disease	6.57e-06	0.000137	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2D6—Alzheimer's disease	6.55e-06	0.000136	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—A2M—Alzheimer's disease	6.54e-06	0.000136	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	6.54e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—LPL—Alzheimer's disease	6.52e-06	0.000136	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	6.38e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	6.38e-06	0.000133	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PLCB1—Alzheimer's disease	6.34e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	6.33e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	6.26e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PLCB1—Alzheimer's disease	6.21e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—BCHE—Alzheimer's disease	6.21e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PLCB1—Alzheimer's disease	6.2e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	6.2e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—A2M—Alzheimer's disease	6.17e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCA1—Alzheimer's disease	6.15e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—A2M—Alzheimer's disease	6.11e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCA1—Alzheimer's disease	6.02e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCA1—Alzheimer's disease	6.01e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.98e-06	0.000124	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—Alzheimer's disease	5.87e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CHAT—Alzheimer's disease	5.86e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TPI1—Alzheimer's disease	5.86e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PLCB1—Alzheimer's disease	5.86e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ACHE—Alzheimer's disease	5.83e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	5.76e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	5.75e-06	0.000119	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ACHE—Alzheimer's disease	5.69e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCA1—Alzheimer's disease	5.68e-06	0.000118	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INPP5D—Alzheimer's disease	5.63e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOB—Alzheimer's disease	5.62e-06	0.000117	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.52e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CALM1—Alzheimer's disease	5.49e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOE—Alzheimer's disease	5.47e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	5.46e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ENO1—Alzheimer's disease	5.46e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	5.45e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAV1—Alzheimer's disease	5.42e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GAPDH—Alzheimer's disease	5.41e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ACHE—Alzheimer's disease	5.36e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	5.36e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	5.35e-06	0.000111	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.33e-06	0.000111	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.33e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ACHE—Alzheimer's disease	5.32e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	5.3e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARGC1A—Alzheimer's disease	5.3e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	5.3e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—HMOX1—Alzheimer's disease	5.28e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	5.26e-06	0.000109	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	5.23e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—A2M—Alzheimer's disease	5.22e-06	0.000109	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARGC1A—Alzheimer's disease	5.19e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARGC1A—Alzheimer's disease	5.18e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—HMOX1—Alzheimer's disease	5.17e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—HMOX1—Alzheimer's disease	5.16e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—BCHE—Alzheimer's disease	5.08e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ENO1—Alzheimer's disease	5.03e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	5.03e-06	0.000105	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ENO1—Alzheimer's disease	4.98e-06	0.000104	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	4.98e-06	0.000104	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.96e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARGC1A—Alzheimer's disease	4.89e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	4.89e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—HMOX1—Alzheimer's disease	4.87e-06	0.000101	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—LPL—Alzheimer's disease	4.82e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	4.79e-06	9.97e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PPARG—Alzheimer's disease	4.76e-06	9.9e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—LPL—Alzheimer's disease	4.73e-06	9.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—LPL—Alzheimer's disease	4.72e-06	9.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.7e-06	9.78e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.68e-06	9.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—BCHE—Alzheimer's disease	4.67e-06	9.72e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—INS—Alzheimer's disease	4.67e-06	9.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	4.66e-06	9.68e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	4.65e-06	9.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—BCHE—Alzheimer's disease	4.63e-06	9.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ACHE—Alzheimer's disease	4.54e-06	9.45e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.53e-06	9.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CHAT—Alzheimer's disease	4.52e-06	9.4e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TPI1—Alzheimer's disease	4.52e-06	9.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INPP5D—Alzheimer's disease	4.49e-06	9.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—LPL—Alzheimer's disease	4.46e-06	9.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	4.41e-06	9.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	4.37e-06	9.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—Alzheimer's disease	4.34e-06	9.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOB—Alzheimer's disease	4.34e-06	9.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.29e-06	8.92e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.27e-06	8.89e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.26e-06	8.85e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.26e-06	8.85e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—Alzheimer's disease	4.25e-06	8.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—Alzheimer's disease	4.25e-06	8.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	4.24e-06	8.81e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.18e-06	8.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	4.17e-06	8.68e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—Alzheimer's disease	4.1e-06	8.52e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CALM1—Alzheimer's disease	4.06e-06	8.44e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—Alzheimer's disease	4.04e-06	8.41e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—A2M—Alzheimer's disease	4.03e-06	8.38e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—Alzheimer's disease	4.01e-06	8.34e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—Alzheimer's disease	4.01e-06	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	4e-06	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	3.99e-06	8.29e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CALM1—Alzheimer's disease	3.98e-06	8.27e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CALM1—Alzheimer's disease	3.97e-06	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—Alzheimer's disease	3.96e-06	8.24e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—BCHE—Alzheimer's disease	3.96e-06	8.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—Alzheimer's disease	3.95e-06	8.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—Alzheimer's disease	3.92e-06	8.16e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—Alzheimer's disease	3.92e-06	8.14e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.91e-06	8.13e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.89e-06	8.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CALM1—Alzheimer's disease	3.75e-06	7.79e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—Alzheimer's disease	3.75e-06	7.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	3.73e-06	7.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—Alzheimer's disease	3.73e-06	7.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—Alzheimer's disease	3.7e-06	7.69e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	3.68e-06	7.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	3.67e-06	7.62e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.66e-06	7.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	3.65e-06	7.59e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—LPL—Alzheimer's disease	3.65e-06	7.58e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	3.63e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	3.62e-06	7.53e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—LPL—Alzheimer's disease	3.56e-06	7.4e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PPARG—Alzheimer's disease	3.52e-06	7.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ACHE—Alzheimer's disease	3.51e-06	7.29e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	3.47e-06	7.21e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—INS—Alzheimer's disease	3.45e-06	7.18e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PPARG—Alzheimer's disease	3.45e-06	7.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PPARG—Alzheimer's disease	3.44e-06	7.16e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—INS—Alzheimer's disease	3.38e-06	7.04e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—INS—Alzheimer's disease	3.38e-06	7.02e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.35e-06	6.97e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—LPL—Alzheimer's disease	3.32e-06	6.91e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ENO1—Alzheimer's disease	3.29e-06	6.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	3.29e-06	6.83e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	3.28e-06	6.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PPARG—Alzheimer's disease	3.25e-06	6.76e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	3.22e-06	6.7e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.2e-06	6.66e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—INS—Alzheimer's disease	3.19e-06	6.63e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.12e-06	6.49e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.11e-06	6.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CALM1—Alzheimer's disease	3.07e-06	6.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—Alzheimer's disease	3.06e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—BCHE—Alzheimer's disease	3.05e-06	6.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—Alzheimer's disease	3.03e-06	6.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—Alzheimer's disease	3.03e-06	6.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.02e-06	6.28e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.99e-06	6.22e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	2.99e-06	6.22e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—Alzheimer's disease	2.98e-06	6.2e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—Alzheimer's disease	2.97e-06	6.17e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—Alzheimer's disease	2.96e-06	6.16e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.96e-06	6.15e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	2.88e-06	5.99e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—LPL—Alzheimer's disease	2.84e-06	5.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CALM1—Alzheimer's disease	2.82e-06	5.87e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—Alzheimer's disease	2.81e-06	5.85e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—Alzheimer's disease	2.8e-06	5.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CALM1—Alzheimer's disease	2.8e-06	5.81e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	2.79e-06	5.81e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—Alzheimer's disease	2.79e-06	5.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—Alzheimer's disease	2.78e-06	5.79e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—Alzheimer's disease	2.77e-06	5.76e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—Alzheimer's disease	2.76e-06	5.74e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—Alzheimer's disease	2.71e-06	5.64e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—Alzheimer's disease	2.71e-06	5.63e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PPARG—Alzheimer's disease	2.66e-06	5.54e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—INS—Alzheimer's disease	2.61e-06	5.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.6e-06	5.4e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—Alzheimer's disease	2.56e-06	5.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.56e-06	5.32e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—INS—Alzheimer's disease	2.55e-06	5.3e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.45e-06	5.09e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PPARG—Alzheimer's disease	2.43e-06	5.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	2.41e-06	5.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—INS—Alzheimer's disease	2.4e-06	4.99e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	2.4e-06	4.98e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.39e-06	4.97e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.38e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—INS—Alzheimer's disease	2.38e-06	4.95e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.36e-06	4.91e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—Alzheimer's disease	2.29e-06	4.76e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.23e-06	4.65e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—LPL—Alzheimer's disease	2.19e-06	4.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.11e-06	4.38e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	2.09e-06	4.35e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—Alzheimer's disease	2.09e-06	4.34e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.07e-06	4.31e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.04e-06	4.25e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—INS—Alzheimer's disease	2.03e-06	4.23e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	1.97e-06	4.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	1.93e-06	4e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	1.91e-06	3.97e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—AKT1—Alzheimer's disease	1.88e-06	3.92e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CALM1—Alzheimer's disease	1.84e-06	3.83e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—Alzheimer's disease	1.84e-06	3.82e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—Alzheimer's disease	1.82e-06	3.79e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—Alzheimer's disease	1.78e-06	3.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.63e-06	3.39e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PPARG—Alzheimer's disease	1.6e-06	3.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—INS—Alzheimer's disease	1.57e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—AKT1—Alzheimer's disease	1.39e-06	2.9e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—Alzheimer's disease	1.38e-06	2.86e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—AKT1—Alzheimer's disease	1.36e-06	2.84e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—AKT1—Alzheimer's disease	1.36e-06	2.83e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—AKT1—Alzheimer's disease	1.29e-06	2.67e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.26e-06	2.62e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.05e-06	2.19e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.03e-06	2.14e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—AKT1—Alzheimer's disease	9.68e-07	2.01e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—AKT1—Alzheimer's disease	9.6e-07	2e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—AKT1—Alzheimer's disease	8.2e-07	1.71e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—AKT1—Alzheimer's disease	6.33e-07	1.32e-05	CbGpPWpGaD
